Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas
Conditions: Type 1 Diabetes; Type 1 Diabetes Mellitus; Hyperglycemia, Postprandial Interventions: Drug: Fiasp; Drug: Pramlintide Acetate; Drug: Placebo; Device: Artificial Pancreas Sponsors: McGill University; Juvenile Diabetes Research Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Carbohydrates | Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Pancreas | Research